Cognitive Behavioral Intervention to Reduce Procedural Anxiety Among Woman With High Risk Pregnancies With Scheduled Cesarean Deliveries
Launched by UNIVERSITY OF COLORADO, DENVER · Dec 17, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special program designed to help women who are facing anxiety before and after having a Cesarean delivery due to high-risk pregnancies. The program uses a technique called cognitive-behavioral therapy, which helps people understand and manage their feelings. Participants will take part in a single session where they will learn about the steps involved in a Cesarean delivery in a setting that looks like an actual operating room. This approach aims to reduce anxiety and improve satisfaction with the delivery experience.
To be eligible for this study, participants must be women planning to have a Cesarean delivery because of complications with their pregnancy, such as issues with the baby's health. Unfortunately, if someone plans to deliver at a different hospital, they won't be able to join the trial. During the study, participants will receive support and follow-up care to see how they feel immediately after and in the weeks following the delivery. This trial is currently looking for women aged between 18 and 45 who meet these criteria.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Fetal Anomaly/Complication
- • Planned Cesarean Delivery
- Exclusion Criteria:
- • Delivery planned at outside hospital
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Houston, Texas, United States
Aurora, Colorado, United States
Kansas City, Missouri, United States
Patients applied
Trial Officials
Allison Dempsey, PhD
Principal Investigator
Children's Hospital Colorado
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials